12/10/2013 9:25:11 AM
HAMBURG, Germany, Dec. 10, 2013 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) (ISIN:DE0005664809) today announced that its research alliance with Boehringer Ingelheim has reached a milestone in November triggering revenues of € 4.0 m to Evotec. The milestone was for the transition of an oncology molecule into pre-clinical development.
Help employers find you! Check out all the jobs and post your resume.
comments powered by